Genor Biopharma IPO: Strong Clinical Pipeline with Some Potential Blockbusters
JHBP (CY) Holdings Ltd also known as Genor Biopharma has filed for an IPO on the Hong Kong Stock Exchange to raise about HK$2.48bn (US$320m). The...
415 Views
JHBP Holdings (Genor Biopharma) IPO Initiation: Hunting for a Cure
$ Genor Biopharma is a biopharmaceutical company focusing on developing and commercializing oncology and autoimmune drugs. Its drug candidates...
487 Views
JHBP/Genor (嘉和生物) Pre-IPO: Thoughts on Valuation
JHBP/Gencor Biopharmaceutical (hereafter Gencor) is a China based biotech company with a focus on oncology and autoimmune drugs with development...
465 Views
ECM Weekly (13 September 2020) - Ant Group, Joy Spreader, Chindata, Huazhu Secondary, Converge ICT
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. In...
534 Views
Genor (嘉和生物) Pre-IPO: Slow R&D Progress in the past but that Might Change
Gencor Biopharmaceutical (hereafter Gencor) is a China based biotech company with a focus on oncology and autoimmune drugs with development...
476 Views